News

 

Ko was awarded the fellowship for his research studying how low levels of androgens facilitate activation of a specific protein, resulting in increased tumor growth. He hopes to develop drugs that exploit this protein signaling process to inhibit prostate cancer cell growth.

Zou is one of several fellows from Duke who will participate in a year of joint institutional activities designed to build awareness and effectiveness in the context of academic leadership. The provosts of the Atlantic Coast Conference member institutions created the Academic Leaders Network Program to develop the leadership potential of participating faculty.

Tavros Therapeutics, co-founded by Kris Wood, PhD, associate professor of pharmacology and cancer biology, and Eoin McDonnell, PhD, a graduate of the Duke University Molecular Cancer Biology PhD Program , has been acquired by Vividion Therapeutics, a subsidiary of global life sciences company Bayer AG.

Binita Chakraborty, PhD, a postdoctoral fellow in the Department of Pharmacology and Cancer Biology, won the Robert and Barbara Bell Basic Science Cancer Research Award for the most innovative basi

Zhao Zhang, PhD, has been promoted to associate professor with tenure, effective January 1, 2025.

Zhao Zhang, PhD, associate professor of pharmacology and cancer biology, has been named a recipient of the 2024 Distinguished Scientist Award (DSA

Thanks to a $50 million gift from an anonymous donor, children will soon be able to get proton therapy at Duke.

The Fall 2024 schedule of the PCB Works in Progress (WIP) series has been released.

The Fall 2024 schedule of the PCB seminar series entitled R